Collectively, these data demonstrated that pattern 1 with membrane expression of CMTM6+PD-L1+ and/or CMTM4+PD-L1+ on the surface of tumor epithelium is associated with better response to anti-PD-1/L1 therapy. The gene discussed is CD274; the disease is neoplasm.